ticlopidine
Ligand Summary
An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
UNII: OM90ZUW7M1
PubChem: 65335
PubChem: 5472
Guide to Pharmacology: 7307
ChEMBL: CHEMBL1717
ChEMBL: CHEMBL833
DrugCentral: 2657
LyCHI: DJTFBY3F8FKR
Target Activities
CYP2B6
Cytochrome P450 2B6
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 6.7 | |||||
Ki | 6.7 | Curr. Drug Metab., (2005) 6:1:413 | ||||
IC50 | 6.22 | J. Med. Chem., (2016) 59:10:4601 | ||||
Ki | 6.1 | Curr. Drug Metab., (2005) 6:1:413 | ||||
IC50 | 6.7 | INHIBITOR | ||||
SIGMAR1
Sigma non-opioid intracellular receptor 1
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 6.75 | None, None:None:None | ||||
IC50 | 6.37 | None, None:None:None | ||||
CYP2C19
Cytochrome P450 2C19
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 7.4 | None, None:None:None | ||||
IC50 | 6.17 | None, None:None:None | ||||
CYP1A2
Cytochrome P450 1A2
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 6.3 | None, None:None:None | ||||
CYP2D6
Cytochrome P450 2D6
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 6.4 | None, None:None:None | ||||
P2RY12
P2Y purinoceptor 12
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
ANTAGONIST | ||||||